Table 5.
Age groups (years) | Infectious disease agents (Subjects) |
Infectious disease agents (Controls) |
||||||
---|---|---|---|---|---|---|---|---|
HBsAg n (%) | HCV n (%) | HIV n (%) VDRL n (%) | VDRL n (%) | HBsAg n (%) | HCV n (%) | HIV n (%) | VDRL n (%) | |
15-19 | 4 (4.9) | 0 (0.0) | 6 (7.3) | 6 (7.3) | 2 (9.5) | Nil (0) | 1 (4.8) | 3 (14.3) |
20-24 | 19 (8.6) | 5 (2.3) | 9 (4.1) | 11 (5.0) | 4 (11.8) | Nil (0) | 6 (17.6) | 1 (2.9) |
25-29 | 16 (4.9) | 0 (0.0) | 9 (2.7) | 17 (5.2) | 9 (11.8) | Nil (0) | 8 (10.5) | 7 (9.2) |
30-34 | 8 (2.9) | 0 (0.0) | 14 (5.1) | 14 (5.1) | Nil (0) | Nil (0) | 6 (16.2) | 3 (8.1) |
35-39 | 3 (3.7) | 0 (0.0) | 3 (3.7) | 4 (4.9) | Nil (0) | Nil (0) | 1 (12.5) | Nil (0) |
40-44 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (8.3) | 2 (8.3) | Nil (0) | Nil (0) | 2 (8.3) |
Total | 50 (5.0) | 5 (0.5) | 41 (4.1) | 53 (5.3) | 17 (8.5) | Nil (0) | 22 (11.0) | 16 (8.0) |
Chi-Square | 9.507 | 17.713 | 4.933 | 0.993 | 5.765 | NA | 6.400 | 3.161 |
P value | 0.09ns | 0.003** | 0.424ns | 0.963ns | 0.330ns | NA | 0.269ns | 0.675ns |
‐Significant at P<0.001; NS ‐ Not significant; NA ‐ Not applicable